High Throughput Screening (HTS) Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
Discover trends, market shifts, and competitive outlooks for the high throughput screening (hts) industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Has the High Throughput Screening (HTS) Market Growth Performance Trended Historically, And What Lies Ahead?
The rapid increase in the size of the high throughput screening (HTS) market in recent years is undeniable. With prospects to appreciate from $22.98 billion in 2024 to $25.49 billion in 2025, it will accrue a compound annual growth rate (CAGR) of 10.9%. This upturn during the historical period can be tied to the accelerated take-up of high-throughput screening, a surge in r&d expenditure, the enlarging pool of research funding, escalating healthcare outlay, and an intensely competitive market environment.
The size of the high throughput screening (HTS) market is anticipated to witness significant expansion in the coming years. It is projected to reach $36 billion in 2029 with a compound annual growth rate (CAGR) of 9.0%. The growth during the forecast period is expected due to factors such as expansion in market size and growth rate, strategic plans by core market players, increasing need for monitoring diseases and drug discovery, a rise in chronic disease prevalence, and an emphasis on employing ultra high throughput screening (UHTS) techniques. The forecast period is characterized by trends such as advanced technology in high-throughput screening and a growing focus on the use of ultra high throughput screening (UHTS) techniques.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the High Throughput Screening (HTS) Market?
The increase in chronic diseases is anticipated to significantly contribute to the expansion of the high-throughput screening (HTS) market. Chronic diseases are long-term health conditions or diseases that last for a minimum of three months. HTS is a quick method for testing various chemical compounds to identify potential drugs that can specifically target pathways or mechanisms in chronic diseases, which are crucial for long-term effective management. For example, the National Library of Medicine, a government agency based in the US, reported in January 2023 that by 2050, the count of individuals aged 50 and older in the US with at least one chronic condition is expected to surge to 142.66 million. As a result, the growth of the high-throughput screening (HTS) market will be driven by the increasing prevalence of chronic diseases.
Which Segments in the High Throughput Screening (HTS) Offer the Most Growth?
The high throughput screening (HTS) market covered in this report is segmented –
1) By Products And Services: Consumables And Reagents, Instruments, Software And Services
2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology
3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications
4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users
Subsegments:
1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents
2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices
3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=14116&type=smp
What Are the Fastest-Growing Geographies in the High Throughput Screening (HTS) Market?
North America was the largest region in the high throughput screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the High Throughput Screening (HTS) Industry?
Leading corporations in the high-throughput screening sector are introducing innovative products including multimode plate readers, offering cutting-edge features to their client base. The multimode plate reader (MPR) is a sophisticated laboratory instrument implemented in high-throughput screening, which examines biological and chemical samples within microplates by combining multiple detection methods for various assays on a single platform. For example, in February 2023, PerkinElmer Inc., a MedTech entity based in the US, introduced the EnVision Nexus system. This system is recognized as the quickest and most sensitive multimode plate reader available, particularly built for challenging high-throughput screening (HTS) uses aimed at accelerating the process of drug discovery. The platform, armed with unique technologies such as dual detectors and optimized reagents like proprietary HTRF and AlphaLISA along with the newest reagent kits, provides researchers with unmatched assay flexibility, precision, pace, and sensitivity. The EnVision Nexus system, furnished with walkaway convenience options like a 20 or 50 plate stacker or complete automation and integration for continuous 24/7 workflow-driven activities, enables researchers to screen millions of samples with remarkable efficiency.
View the full report here:
https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report
What Are the Key Elements That Define the High Throughput Screening (HTS) Market?
High-throughput screening (HTS) is a technique employed in drug discovery and various scientific domains to rapidly assess a large number of samples for biological activity. Its purpose is to identify active compounds, antibodies, or genes that modulate specific biological pathways, thereby expediting the drug discovery process.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14116
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model